IRF6 and Hepatic fibrosis: Our results indicate that Pit (0.8 mg/kg) can reverse liver fibrosis by targeting two main pathways—NF‐κB and PI3K/Nrf2/HO‐1—that capture inflammation, oxidative stress, and proliferation.